Sabrina Ibadioune
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Constitutional BRCA1 Methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer.
Journal: NPJ breast cancer
Published: November 03, 2025
Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoter.
Journal: Clinical epigenetics
Published: March 24, 2025
High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer.
Journal: Clinical epigenetics
Published: January 14, 2025
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Journal: Breast (Edinburgh, Scotland)
Published: November 17, 2023
Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
Journal: Journal of medical genetics
Published: April 07, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 29, 2022
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Journal: Nature communications
Published: April 14, 2022
Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 19, 2022
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
Journal: Molecular oncology
Published: August 04, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026